ÂÜÀòÂÒÂ×

Prof. Raymond G. Hill is currently Honorary Professor of Pharmacology, Faculty of Medicine Imperial College, London. He is part of a research group using fMRI to investigate whether substance P antagonism might help patients with opioid use disorder and teaches on postgraduate courses on drug discovery and translational pharmacology.

He started his career as a University academic active in teaching and research in Pharmacology (1974 to 1988). From 1990 until his retirement in 2008 he worked in drug discovery research for Merck / MSD. He was Executive Director, Pharmacology at the UK Neuroscience Research Centre engaged in drug discovery for Neuroscience indications, with global responsibility for Pain and Headache targets. He also (1997-2002) had oversight responsibility for Neuroscience research at the Banyu Research Labs in Tsukuba, Japan. He chaired a number of discovery project teams including those responsible for the marketed products Maxalt® and Emend®.

Dr Hill is Visiting Industrial Professor of Pharmacology in the University of Bristol and has been Visiting Professor at the University of Surrey and at Strathclyde University. He is President Emeritus British Pharmacological Society and was, among others, a Member of Council, Academy of Medical Sciences and a member of the UK Government Advisory Council on the Misuse of Drugs.

Dr Hill has published more than 250 peer reviewed papers on neuropharmacology. He is co-author (with J.A. Alexander) of a text book on Postoperative Pain Control and (with D Richards) of one on Drug Discovery and Development.